Women with lesion history need smear tests after 60

Women should be offered annual smear tests for at least 25 years after treatment for precancerous lesions, say Swedish researchers.

Recent findings indicate that women are still at risk of developing invasive cancer of the cervix even after treatment for grade-three cervical intraepithelial neoplasmia. This emphasises the need for regular screening even beyond the age of 60, say the researchers.

Data from the National Swedish Cancer Register on 132,493 women, recorded between 1958 and 2002, who had a diagnosis of severe dysplasia, was examined.

Using patient registration numbers, it was noted that 881 women had a diagnosis of invasive cervical cancer and 111 women had a diagnosis of vaginal cancer more than one year after undergoing treatment for severe dysplasia. Increased risk of cervical cancer in women who were aged 35 plus when treated for severe dysplasia was also found.

Women were two fold more likely to develop invasive cervical cancer after a diagnosis of severe dysplasia if the diagnosis was made between 1991 and 2000 than between 1958 and 1970.

Lead researcher Dr Bjorn Strander, senior consultant at the department of obstetrics and gynaecology at the University of Gothenburg, said: 'It must be considered a failure of the medical service when women participate in screening, their precancerous lesions are found, they subject themselves to treatment of those lesions, presumably participate in follow-up programmes and still develop invasive cancer.'

Follow-up care has been insufficient and women should be offered annual smear tests for at least 25 years after treatment, said Dr Strander.

Long-term follow-up should not stop for women when they reach the age of 60 if they were older than 35 at the time of treatment, he added.

sanjay.tanday@haymarket.com

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

NHS England pledges £30m for GPs to boost long COVID diagnosis and care

NHS England pledges £30m for GPs to boost long COVID diagnosis and care

NHS England has promised £30m for general practice to improve diagnosis and care...

Second dose COVID jabs for over-40s to be accelerated as lifting restrictions is delayed

Second dose COVID jabs for over-40s to be accelerated as lifting restrictions is delayed

Second doses of COVID-19 vaccines in England will be 'accelerated' for all over-40s...

BMA backs negligence action against GMC and hospital over doctor's suicide

BMA backs negligence action against GMC and hospital over doctor's suicide

The BMA is supporting legal action over alleged negligence and under the Human Rights...

GPs recognised in Queen's birthday honours

GPs recognised in Queen's birthday honours

GPs are among those who have been recognised in the Queen's birthday honours.

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

The healthcare crisis in Myanmar - how UK GPs can help

The healthcare crisis in Myanmar - how UK GPs can help

Dr Jim Brockbank from Myanmar UK GP Health Action provides an update on how the military...